Shenzhen People's Hospital

Covers the complete chain of coronary intervention, congenital heart disease and structural heart disease (TAVR/TEER), complex arrhythmia ablation, heart failure and cardiomyopathy management, cardiac surgery bypass/valve surgery, etc. Equipped with hybrid operating room and image fusion navigation, electrophysiology and structural heart intervention cooperate on the same stage, and the acute chest pain green channel operates 24/7.

Multidisciplinary MDT-led precision treatment system, routinely performs IMRT/VMAT, SRS/SBRT, and implements molecular subtyping and individualized programs in conjunction with PET-CT and gene detection; establishes a radiotherapy planning and quality control platform for high-precision radiotherapy and comprehensive treatment of complex areas such as head and neck, chest, abdomen and pelvis, and bone metastasis.

National-level stroke center construction standards, opening emergency endovascular treatment channels for stroke, aneurysms, and vascular malformations; neurosurgery has comprehensive capabilities in skull base tumors, gliomas, epilepsy surgery, and deep brain stimulation (DBS), combined with intraoperative navigation and intraoperative imaging to improve surgical safety and overall rehabilitation efficiency.

Kidney transplantation and blood purification are the dominant directions, and living/deceased donor kidney transplantation and post-transplantation follow-up management are carried out in a standardized manner, integrating dialysis, peritoneal dialysis, and transplantation; the transplantation immune monitoring and infection prevention and control system is complete, and it cooperates with urology, infection, imaging and other disciplines.

Based on the da Vinci robot platform, it covers minimally invasive treatment of urology, general surgery, gynecology, cardiothoracic surgery and other specialized diseases. The dominant diseases include radical prostatectomy, rectal cancer TME, gastric cancer D2, endometrial cancer staging and lung segment resection; an ERAS accelerated rehabilitation pathway is established to shorten hospital stay and complication rate.

Focuses on TAVR/TEER, left atrial appendage closure, atrial septal defect/ventricular septal defect closure, etc., with preoperative CT and transesophageal ultrasound three-dimensional evaluation, intraoperative image fusion navigation and anesthesia management to achieve minimally invasive and standardized treatment of complex valvular diseases.

Builds high-throughput sequencing (NGS), liquid biopsy, and pharmacogenomics platforms, combined with tumor molecular subtyping, genetic rare disease diagnosis, and infectious pathogen metagenomic testing to promote the translation of scientific research results into clinical practice and establish a molecular tumor MDT and medication guidance system.

Performs high-difficulty diagnosis and treatment such as ESD/EMR, POEM, ERCP/EUS, and implements minimally invasive endoscopic treatment for early gastrointestinal tumors, achalasia, and biliary and pancreatic diseases; introduces AI-assisted diagnosis and chromoendoscopy/magnifying endoscopy to improve early cancer detection.

Complex spinal deformity correction, minimally invasive intervertebral fusion, limb joint replacement and revision, and arthroscopic reconstruction of sports injuries; with the help of intraoperative navigation, 3D-printed personalized osteotomy guides, and accelerated rehabilitation programs, functional recovery and long-term survival rates are improved.

Perinatal medicine and high-risk pregnancy management, fetal medicine ultrasound evaluation, standardized reproductive endocrinology and assisted reproduction-related diagnosis and treatment (qualifications are subject to official announcements), and integrated maternal and infant treatment with the Department of Neonatology (NICU).